Molecular mechanisms of cisplatin resistance

Galluzzi, L, Senovilla, L, Vitale, I, Michels, J, Martins, I, Kepp, O, Castedo, M, Kroemer, G·2012·Oncogene
DOI 10.1038/onc.2011.384

Cited by (1,001)

Items 401–500 of 1,001

  1. Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck
    Kelsey P. Pendleton, Jennifer Rubin Grandis · 2013 · Clinical Medicine Insights Therapeutics
  2. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
    Cristine L. Chisholm, Haitao Wang, Ada Hang‐Heng Wong, Guelaguetza Vázquez-Ortíz, Weiping Chen, Xiaoling Xu, Chu‐Xia Deng · 2016 · Oncotarget
  3. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
    Pavel Štarha, Radka Křikavová · 2023 · Coordination Chemistry Reviews
  4. MCL-1 dependency of cisplatin-resistant cancer cells
    Judith Michels, Florine Obrist, Ilio Vitale, Delphine Lissa, Pauline Garcia, Parviz Behnam‐Motlagh, Kimitoshi Kohno, Gen Sheng Wu, Catherine Brenner, Maria Castedo et al. · 2014 · Biochemical Pharmacology
  5. Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma
    Jian Gao, Sen Zhao, Trond S. Halstensen · 2016 · Oncology Reports
  6. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
    Haiyan Zhu, Jun Wu, Wenwen Zhang, Hui Luo, Zhaojun Shen, Huihui Cheng, Xueqiong Zhu · 2016 · Scientific Reports
  7. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
    Amnani Aminuddin, Pei Yuen Ng, Chee‐Onn Leong, Eng Wee Chua · 2020 · Scientific Reports
  8. WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
    Hongping Zheng, Fangyuan Shao, Scots Martin, Xiaoling Xu, Chu‐Xia Deng · 2017 · Scientific Reports
  9. Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery
    Sung Soo Park, Moon Hyun Jung, Young-Shin Lee, Jae-Ho Bae, Sun-Hee Kim, Chang‐Sik Ha · 2019 · Materials & Design
  10. Targeting the tumour microenvironment in platinum-resistant ovarian cancer
    Michele Cummings, Clare Freer, Nicolas Michel Orsi · 2021 · Seminars in Cancer Biology
  11. Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
    Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, Kalkidan Getnet, Abebe Belete Bitew, Mebrie Zemene Kinde, Asnakew Mulaw Berihun, Atsede Solomon Mebratu, Yesuneh Tefera Mekasha, Melaku Getahun Feleke et al. · 2024 · Cancer Cell International
  12. Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis
    Y Lei, Beric R. Henderson, C Emmanuel, Paul R. Harnett, Anna DeFazio · 2014 · Oncogene
  13. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma
    Renata Colla, Alberto Izzotti, Chiara De Ciucis, Daniela Fenoglio, Silvia Ravera, Andrea Speciale, Roberta Ricciarelli, Anna Lisa Furfaro, Alessandra Pulliero, Mario Passalacqua et al. · 2016 · Oncotarget
  14. Les 50 ans du cisplatine
    C. Rancoule, Jean‐Baptiste Guy, Alexis Vallard, Majed Ben Mrad, Amel Rehailia-Blanchard, Nicolas Magné · 2016 · Bulletin du Cancer
  15. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells
    Zhangding Wang, Qiang Wang, Guifang Xu, Na Meng, Xinli Huang, Zerun Jiang, Chen Chen, Yan Zhang, Junjie Chen, Aiping Li et al. · 2019 · RNA Biology
  16. Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies
    Vaishnavi Muralikrishnan, Thomas D. Hurley, Kenneth P. Nephew · 2020 · Cancers
  17. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review
    Masoud Najafi, Shima Tavakol, Ali Zarrabi, Milad Ashrafizadeh · 2020 · Archives of Physiology and Biochemistry
  18. Exosomal MiR‐500a‐3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer
    Lin Hao, Liang Zhang, Caihua Zhang, Pengpeng Liu · 2020 · Journal of Cellular and Molecular Medicine
  19. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
    Chao Jing, Yuansheng Duan, Mengqian Zhou, Kai Yue, Shanshan Zhuo, Xingchen Li, Dandan Liu, Beibei Ye, Qingchuan Lai, Linqi Li et al. · 2021 · Theranostics
  20. Cellular Levels of Oxidative Stress Affect the Response of Cervical Cancer Cells to Chemotherapeutic Agents
    Maria Filippova, Valery A. Filippov, Vonetta Michelle Williams, Kangling Zhang, Anatolii Kokoza, Svetlana Bashkirova, Penelope J. Duerksen-Hughes · 2014 · BioMed Research International
  21. Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation
    Magali Castells, Delphine Milhas, C Gandy, Benoît Thibault, Arash Rafii, Jean‐Pierre Delord, Bettina C. Couderc · 2013 · Cell Death and Disease
  22. Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells
    Suneetha Nunna, Richard Reinhardt, Sergey Ragozin, Albert Jeltsch · 2014 · PLoS ONE
  23. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells)
    Kalai Selvi Sivalingam, Amirthalingam Vinoth, Varadharajan Thiyagarajan, Ching‐Feng Weng, Viswanadha Vijaya Padma · 2017 · Food and Chemical Toxicology
  24. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells
    Danfeng Xue, Shuting Pan, Gan Huang, Jiaxuan Qiu · 2020 · The International Journal of Biochemistry & Cell Biology
  25. miR-29b Mediates NF-κB Signaling in KRAS-Induced Non–Small Cell Lung Cancers
    Stephanie Langsch, Ulrich Baumgartner, Stefan Haemmig, Cornelia Schlup, Stephan Christian Schäfer, Sabina Berezowska, Gregor Rieger, Patrick Dorn, Mario P. Tschan, Erik Vassella · 2016 · Cancer Research
  26. Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
    Leirong Wang, Leina Ma, Fei Xu, Wenxin Zhai, Shenghua Dong, Ling Yin, Jia Liu, Zhuang Yu · 2018 · Thoracic Cancer
  27. Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells
    Luca X. Zampieri, Debora Grasso, Caroline Bouzin, Davide Brusa, Rodrigue Rossignol, Pierre Sonveaux · 2020 · Molecular Cancer Research
  28. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription
    Yunyao Liu, Xiaoping Wang, Wenshu Li, Yujiao Xu, Yating Zhuo, Mengyuan Li, Yuan Zhang He, Xiaosheng Wang, Qinglong Guo, Li Zhao et al. · 2020 · Oncogene
  29. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
    P-N Teng, G Wang, B L Hood, K A Conrads, Chad A. Hamilton, G. Larry Maxwell, K.M. Darcy, Thomas P. Conrads · 2013 · British Journal of Cancer
  30. Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis through c-MYC and HIF-1α in EGFR-Mutated Lung Cancer In Vitro and In Vivo
    Jasmine G. Lee, Reen Wu · 2015 · Neoplasia
  31. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol
    Rabbab Oun, Jane A. Plumb, Nial Wheate · 2014 · Journal of Inorganic Biochemistry
  32. The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
    M. Juliachs, C. Muñoz, Cátia Moutinho, August Vidal, Enric Condom, Manel Esteller, Mariona Graupera, Oriol Casanovas, J.R. Germà, Alberto Villanueva et al. · 2013 · Clinical Cancer Research
  33. Polymeric micelles for targeted tumor therapy of platinum anticancer drugs
    Yuki Mochida, Horacio Cabral, Kazunori Kataoka · 2017 · Expert Opinion on Drug Delivery
  34. The inducers of immunogenic cell death for tumor immunotherapy
    Xiuying Li · 2017 · Tumori Journal
  35. An ultrasensitive fluorogenic probe for revealing the role of glutathione in chemotherapy resistance
    Yuejing Jiang, Juan Cheng, Chengyu Yang, Yongzhou Hu, Jia Xuan Li, Yifeng Han, Yi Zang, Xin Li · 2017 · Chemical Science
  36. High-capacity poly (2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
    Vinod, Natasha, Hwang, Duhyeong, Azam, Salma H., Van Swearingen, Amanda E. D., Wayne, Elizabeth, Fussell, Sloane Christian, Sokolsky-Papkov, Marina, Pecot, Chad V., Kabanov, Alexander V. · 2020 · Science Advances
  37. Replication protein A availability during DNA replication stress is a major determinant of cisplatin resistance in ovarian cancer cells
    Bélanger, François, Fortier, Emile, Dubé, Maxime, Lemay, Jean-François, Buisson, Rémi, Masson, Jean-Yves, Elsherbiny, Abdelhamid, Costantino, Santiago, Carmona, Euridice, Mes-Masson, Anne-Marie et al. · 2018 · Cancer Research
  38. Metal complexes of alkyl-aryl dithiocarbamates: Structural studies, anticancer potentials and applications as precursors for semiconductor nanocrystals
    Fartisincha P. Andrew, Peter Adewale Ajibade · 2017 · Journal of Molecular Structure
  39. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
    Cheng Wang, Zhihong Zhou, Charannya Sozheesvari Subhramanyam, Qiong Cao, Zealyn Shi‐Lin Heng, Wen Liu, Xiang‐Dong Fu, Qidong Hu · 2020 · Communications Biology
  40. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
    Yinan Xiao, Ling Jin, Chaolin Deng, Ye Guan, Eleftheria Kalogera, Upasana Ray, Prabhu Thirusangu, Julie K. Staub, Sayantani Sarkar Bhattacharya, Haotian Xu et al. · 2021 · Oncogene
  41. Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
    Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, Seema Singh, Annelise Wilhite, Santanu Dasgupta, Rodney Paul Rocconi, Ajay Pratap Singh · 2021 · Seminars in Cancer Biology
  42. Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
    W. Ruprecht Wiedemeyer, Jessica A. Beach, Beth Y. Karlan · 2014 · Frontiers in Oncology
  43. Subpopulation of small‐cell lung cancer cells expressing CD 133 and CD 87 show resistance to chemotherapy
    Toshio Kubo, Nagio Takigawa, Masahiro Osawa, Daijiro Harada, Takashi Ninomiya, Nobuaki Ochi, Eiki Ichihara, Hiromichi Yamane, Mitsune Tanimoto, Katsuyuki Kiura · 2012 · Cancer Science
  44. Treatment resistance in urothelial carcinoma: an evolutionary perspective
    Panagiotis J. Vlachostergios, Bishoy M. Faltas · 2018 · Nature Reviews Clinical Oncology
  45. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein
    Brian Kawahara, Sivakumar Ramadoss, Gautam Chaudhuri, Carla Janzen, Suvajit Sen, Pradip K. Mascharak · 2018 · Journal of Inorganic Biochemistry
  46. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it
    Himanshu Verma, Malkeet Singh Bahia, Shalki Choudhary, Pankaj Kumar Singh, Om Silakari · 2019 · Drug Metabolism Reviews
  47. Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Giovanni Motterle, Jack R. Andrews, Alessandro Morlacco, Robert Jeffrey Karnes · 2019 · European Urology Focus
  48. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance
    Wantong Song, Zhaohui Tang, Na Shen, Haiyang Yu, Yanjie Jia, Dawei Zhang, Jian Wei Jiang, Chaoliang He, Huayu Tian, Xuesi Chen · 2016 · Journal of Controlled Release
  49. Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)
    Kohei Shitara, Toshihiko Doi, Osamu Nagano, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Takeshi Kuwata, Kai Asai, Yasuaki Einaga et al. · 2017 · Gastric Cancer
  50. Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
    Claire Lhuillier, Claire Vanpouille‐Box, Lorenzo Galluzzi, Silvia Chiara Formenti, Sandra Demaria · 2017 · Seminars in Cancer Biology
  51. Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer
    Stephen Shang, Jiekun Yang, Amir Anthony Jazaeri, Alexander James Duval, Turan Tufan, Natasha Lopes Fischer, Mouadh Benamar, Fadila Guessous, In-Young Lee, Robert M. Campbell et al. · 2019 · Cancer Research
  52. Tumor metabolism regulating chemosensitivity in ovarian cancer
    Chae Young Han, David A. Patten, Richard B. Richardson, Mary‐Ellen Harper, Benjamin K. Tsang · 2018 · Genes & Cancer
  53. EGCG inhibits CSC‐like properties through targeting miR‐485/CD44 axis in A549‐cisplatin resistant cells
    Pan Jiang, Chuyue Xu, Lijun Chen, Aochang Chen, Xiaoyue Wu, Ming Zhou, Ijaz ul Haq, Zahula Mariyam, Qing Feng · 2018 · Molecular Carcinogenesis
  54. The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells
    Abdelhabib Semlali, Camille Contant, Basem Al‐Otaibi, Ibrahim Al‐Jammaz, Fatiha Chandad · 2021 · Scientific Reports
  55. Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer
    Chunjing Wu, Sydney A. Spector, George Theodoropoulos, Dan J.M. Nguyen, Emily Kim, Ashley Garcia, Niramol Savaraj, Diane C Lim, Ankita Paul, Lynn G. Feun et al. · 2023 · Cancer & Metabolism
  56. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3
    Jing Zhang, Heng Wei, Xia Liu, Ning Wang, Yafei Qi, Yao Zhang, Zhang Shulan · 2015 · Cancer Biology & Therapy
  57. β-Phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype
    Wen-jing Wu, Yan Zhang, Zhao-Lei Zeng, Xiao-bing Li, Kai-shun Hu, Hui Luo, Jing Yang, Peng Huang, Rui‐Hua Xu · 2012 · Biochemical Pharmacology
  58. MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1
    Xiao He, Xia Xiao, Lin Dong, Nengbin Wan, Zhengyu Zhou, Hongwu Deng, Xiefu Zhang · 2014 · Tumor Biology
  59. Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
    Carlos D Gamarra-Luques, Alicia Alejandra Goyeneche, María Belén Hapon, Carlos Marcelo Telleria · 2012 · BMC Cancer
  60. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation
    Belinda Halling Sørensen, Dorthe Nielsen, Unnur Arna Thorsteinsdottir, Else Kay Hoffmann, Ian Henry Lambert · 2016 · American Journal of Physiology-Cell Physiology
  61. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1
    Ying Liu, Z Niu, Xueyan Lin, Ye Tian · 2017 · Cancer Gene Therapy
  62. USP22 Induces Cisplatin Resistance in Lung Adenocarcinoma by Regulating γH2AX-Mediated DNA Damage Repair and Ku70/Bax-Mediated Apoptosis
    Aman Wang, Zhen Ning, Chang Lu, Wei Gao, Jinxiao Liang, Qiu Yan, Guang Tan, Jiwei Liu · 2017 · Frontiers in Pharmacology
  63. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
    Wenxia Xu, Qi Wei, Mengjiao Han, Bingluo Zhou, Hanying Wang, Jianbing Zhang, Qiang Wang, Jie Sun, Lifeng Feng, Shouyu Wang et al. · 2018 · International Journal of Biological Sciences
  64. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell
    Wan, Xingyou, Wang, Chao, Huang, Zhenyu, Zhou, Dejian, Xiang, Sheng, Qi, Qian, Chen, Xinyuan, Arbely, Eyal, Liu, Chen-Ying, Du, Peng et al. · 2020 · Cell Death & Disease
  65. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance
    Daphna Mokady, David Meiri · 2015 · Drug Resistance Updates
  66. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells
    Zhihai Zheng, You He-yi, Yujie Feng, Zhongtao Zhang · 2020 · Molecular and Cellular Biochemistry
  67. lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5
    Yingying Jiang, Haiyan Guo, Tong Tong, Fei Xie, Xing Qin, Xiaoning Wang, Wantao Chen, Jianjun Zhang · 2021 · Molecular Therapy
  68. Is Autophagy Always a Barrier to Cisplatin Therapy?
    Jingwen Xu, David A. Gewirtz · 2022 · Biomolecules
  69. A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
    Philipp Fronik, Michael Gutmann, Petra Vician, Mirjana Stojanovic, Alexander Kastner, Petra Heffeter, Christine Pirker, Bernhard K. Keppler, Walter Berger, Christian R. Kowol · 2022 · Communications Chemistry
  70. JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
    Wei Xu, Qi Chen, Qiang Wang, Yanlan Sun, S Wang, Ao Li, Shiqin Xu, Oluf Dimitri Røe, M Wang, Rong Zhang et al. · 2014 · Cell Death and Disease
  71. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
    Chia-Sing Lu, Gia-Shing Shieh, Chung-Teng Wang, Bing‐Hua Su, Yu‐Chu Su, Yi-Cheng Chen, Wu‐Chou Su, Pensée Wu, Wen‐Horng Yang, Ai‐Li Shiau et al. · 2016 · Oncotarget
  72. Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
    Jessica M. Hearn, George M. Hughes, Isolda Romero‐Canelón, Alison F. Munro, Belén Rubio‐Ruíz, Zhe Liu, Neil O. Carragher, Peter John Sadler · 2017 · Metallomics
  73. Intraoperative Raman‐Guided Chemo‐Photothermal Synergistic Therapy of Advanced Disseminated Ovarian Cancers
    Yuqing Zhang, Zhiyang Liu, Benjamin D. Thackray, Zhouzhou Bao, Xia Yin, Fenglei Shi, Jianbo Wu, Jian Ye, Wen J. Di · 2018 · Small
  74. Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
    João Lobo, Cármen Jerónimo, Rui Henrique · 2020 · Cancers
  75. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
    Suresh Bugide, Vijay K. Gonugunta, Vasudevarao Penugurti, Vijaya Lakshmi Malisetty, Ratna K. Vadlamudi, Bramanandam Manavathi · 2016 · Cellular Oncology
  76. ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells
    Ze Yu, Weifan Cao, Yuan Ren, Qijia Zhang, Jia Liu · 2020 · Clinical and Translational Medicine
  77. Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
    Ana Belén Griso-Acevedo, Lucía Acero-Riaguas, Beatriz Castelo, José Luis Cebrián Carretero, Ana Sastre-Perona · 2022 · Cells
  78. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
    Mohamed Aly Haider, Amr Elsherbeny, Valeria Pittalà, Antonino Nicolò Fallica, Maha Ali Alghamdi, Zahid Hussain, Ghalia Khoder, Khaled F. Greish · 2022 · International Journal of Molecular Sciences
  79. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
    Andrew J. Wilson, Jeanette L. Saskowski, Whitney Jo Barham, Fiona E. Yull, Dineo Khabele · 2015 · Journal of Ovarian Research
  80. Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer
    Fernanda Musa, Amandine Alard, Gizelka David‐West, John Patrick Curtin, Stephanie V. Blank, Robert J. Schneider · 2016 · Molecular Cancer Therapeutics
  81. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21<sup>WAF1/CIP1</sup>
    Xu, Shun, Huang, Haijiao, Chen, Yu-ning, Deng, Yun-ting, Zhang, Bing, Xiong, Xing-dong, Yuan, Yuan, Zhu, Yanmei, Huang, Haiyong, Xie, Luoyijun et al. · 2016 · Cell Cycle
  82. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
    Chia‐Wen Liu, Kuo‐Tai Hua, Kaichun Li, Hsiang‐Fong Kao, Ruey‐Long Hong, Jenq‐Yuh Ko, Michael Hsiao, Min‐Liang Kuo, Ching‐Ting Tan · 2017 · Molecular Cancer Therapeutics
  83. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo
    Tian-He Song, Xiaoxin Chen, Ckf Lee, Stephen Cho Wing Sze, Yibin Feng, Zhijun Yang, Haiyong Chen, Sheng-Tao Li, Liyan Zhang, Gang Wei et al. · 2018 · Phytomedicine
  84. Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells
    Huahong Yang, Yun Gao, Xiaoye Fan, Xingkai Liu, Liping Peng, Xinxin Ci · 2019 · Frontiers in Oncology
  85. Selective killing of p53‐deficient cancer cells by SP600125
    Mohamed Jèmaà, Ilio Vitale, Oliver Kepp, Francesco Berardinelli, Lorenzo Galluzzi, Laura Senovilla, Guillermo Mariño, Shoaib Ahmad Malik, Santiago Rello‐Varona, Delphine Lissa et al. · 2012 · EMBO Molecular Medicine
  86. Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
    Christophe Deben, Vanessa Deschoolmeester, Jorrit De Waele, Julie Jacobs, Jolien Van den Bossche, An Wouters, Marc Peeters, Christian D. Rolfo, Evelien Smits, Filip Lardon et al. · 2018 · Cancers
  87. A mitochondria-targeting hetero-binuclear Ir( iii )–Pt( ii ) complex induces necrosis in cisplatin-resistant tumor cells
    Cheng Ouyang, Lei Chen, Thomas W. Rees, Yu Chen, Jiankang Liu, Liang‐Nian Ji, Jiangang Long, Hui Chao · 2018 · Chemical Communications
  88. Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review
    Mudra Binju, Monica Angelica Amaya-Padilla, Terence Singomat, Pritinder Kaur, Yohan Suryo Rahmanto, Paul Andrew Cohen, Yu Yu · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  89. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells
    Yan Li, Ying Chen, Liyun Miao, Yongsheng Wang, Min Yu, Xin Yan, Qi Zhao, Hourong Cai, Yonglong Xiao, Guichun Huang · 2020 · Cancer Letters
  90. Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells
    Guang-Ping Zou, Chunxia Yu, Sheng-Lan Shi, Qiu-Gen Li, Xiao-Hua Wang, Xin-Hui Qu, Zhang‐Jian Yang, Wei-Rong Yao, Dandan Yan, Liping Jiang et al. · 2021 · Journal of Cancer
  91. HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
    Xiaoniu He, Yuanpei Li, Jian Li, Yu Li, Sijie Chen, Yan Xia, Zhangrong Xie, Jiangfeng Du, Guoan Chen, Jianbo Song et al. · 2025 · Advanced Science
  92. Rational Design of a Cytotoxic Dinuclear Cu2 Complex That Binds by Molecular Recognition at Two Neighboring Phosphates of the DNA Backbone
    Thomas Jany, Alexander Moreth, Claudia Horstmann née Gruschka, Andy Sischka, Andre Spiering, Mareike Dieding, Ying Wang, Susan Haji Samo, Anja Stammler, Hartmut Bögge et al. · 2015 · Inorganic Chemistry
  93. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
    Xin Zhang, Yanli Zhang, Xinfeng Liu, Aiju Fang, Peilong Li, Zewu Li, Tong Liu, Yongmei Yang, Lutao Du, Chuanxin Wang · 2015 · PLoS ONE
  94. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival
    Chun-Hua Dai, Ping Chen, Jian Li, Tin Lan, Yongchang Chen, Hai Qian, Kang Chen, Meiyu Li · 2016 · Oncotarget
  95. Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin
    Cale D. Fahrenholtz, Jessica L. Swanner, Maria Ramirez-Perez, Ravi N. Singh · 2017 · Journal of Nanomaterials
  96. Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer
    Masayuki Hagiwara, Eiji Kikuchi, Nobuyuki Tanaka, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya · 2018 · BMC Cancer
  97. Synthesis, characterization and anticancer studies of bis(1-phenylpiperazine dithiocarbamato) Cu(II), Zn(II) and Pt(II) complexes: Crystal structures of 1-phenylpiperazine dithiocarbamato-S,S′ zinc(II) and Pt(II)
    Fartisincha P. Andrew, Peter Adewale Ajibade · 2018 · Journal of Molecular Structure
  98. Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications
    Ilaria Fratoddi, Iole Venditti, Chiara Battocchio, Laura Carlini, Simone Amatori, Marina Porchia, Francesco Tisato, Federica Bondino, Elena Magnano, Maura Pellei et al. · 2019 · Nanomaterials
  99. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling
    Na Wang, Lele Song, Yi Xu, Longfu Zhang, Yanjun Wu, Jingyu Guo, Weiwei Ji, Li Li, Jingya Zhao, Xin Zhang et al. · 2019 · EBioMedicine
  100. The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy
    Adrián E. Granada, Alba Jiménez, Jacob Stewart-Ornstein, Nils Blüthgen, Simone Reber, Ashwini Jambhekar, Galit Lahav · 2020 · Molecular Biology of the Cell